Kengo Kawai

723 total citations
26 papers, 584 citations indexed

About

Kengo Kawai is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Kengo Kawai has authored 26 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Kengo Kawai's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver physiology and pathology (6 papers). Kengo Kawai is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver physiology and pathology (6 papers). Kengo Kawai collaborates with scholars based in Japan, China and Italy. Kengo Kawai's co-authors include Toshiro Sugiyama, Terumi Takahara, Yutaka Yata, Takeshi Takahara, Wei Zhang, Kazuhiro Tsukada, Kazuto Tajiri, Hiroshi Kudo, Xiao‐Kang Li and Xiaoyu Luo and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Kengo Kawai

24 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kengo Kawai Japan 11 342 181 130 94 87 26 584
Adam Levene United Kingdom 11 339 1.0× 161 0.9× 137 1.1× 130 1.4× 110 1.3× 19 599
Mehdi Ramezani–Moghadam Australia 10 444 1.3× 207 1.1× 121 0.9× 98 1.0× 90 1.0× 11 610
Yosuke Aihara Japan 15 340 1.0× 218 1.2× 137 1.1× 149 1.6× 111 1.3× 28 584
Tomohiko Ohashi Japan 14 314 0.9× 152 0.8× 94 0.7× 153 1.6× 159 1.8× 38 612
Hyo‐Suk Lee South Korea 13 290 0.8× 163 0.9× 214 1.6× 82 0.9× 106 1.2× 24 634
Jennifer Demieville United States 13 225 0.7× 182 1.0× 117 0.9× 73 0.8× 143 1.6× 16 523
Ali Mencin United States 6 340 1.0× 242 1.3× 176 1.4× 48 0.5× 117 1.3× 7 670
Nozomu Wada Japan 15 243 0.7× 285 1.6× 115 0.9× 61 0.6× 116 1.3× 45 560
Rie Irie Japan 14 390 1.1× 285 1.6× 186 1.4× 119 1.3× 229 2.6× 56 827
Sara Aleffi Italy 10 550 1.6× 324 1.8× 148 1.1× 97 1.0× 159 1.8× 14 803

Countries citing papers authored by Kengo Kawai

Since Specialization
Citations

This map shows the geographic impact of Kengo Kawai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kengo Kawai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kengo Kawai more than expected).

Fields of papers citing papers by Kengo Kawai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kengo Kawai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kengo Kawai. The network helps show where Kengo Kawai may publish in the future.

Co-authorship network of co-authors of Kengo Kawai

This figure shows the co-authorship network connecting the top 25 collaborators of Kengo Kawai. A scholar is included among the top collaborators of Kengo Kawai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kengo Kawai. Kengo Kawai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tajiri, Kazuto, Kazuhiko Okada, Hiroyuki Ito, et al.. (2023). Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals. BMC Gastroenterology. 23(1). 182–182.
2.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Kengo Kawai, et al.. (2023). Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma. Oncology. 102(2). 131–140. 2 indexed citations
3.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Kengo Kawai, et al.. (2022). Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study. Anticancer Research. 42(12). 6007–6018. 3 indexed citations
4.
Tajiri, Kazuto, Hiroyuki Ito, Kengo Kawai, et al.. (2022). Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma. World Journal of Hepatology. 14(6). 1190–1199. 3 indexed citations
5.
Tajiri, Kazuto, Yoshiharu Tokimitsu, Yoshinari Atarashi, et al.. (2018). Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Digestive Diseases. 36(4). 314–321. 9 indexed citations
6.
Tajiri, Kazuto, Akinori Wada, Koichi Tsuneyama, et al.. (2018). A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma. Internal Medicine. 57(14). 2013–2018. 2 indexed citations
7.
Tajiri, Kazuto, Hayato Baba, Kengo Kawai, et al.. (2016). Neutrophil‐to‐lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection. Journal of Gastroenterology and Hepatology. 31(7). 1291–1299. 37 indexed citations
8.
Tajiri, Kazuto, Kengo Kawai, & Toshiro Sugiyama. (2016). Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases. Journal of Gastroenterology. 52(6). 724–733. 8 indexed citations
9.
Baba, Hayato, Kazuto Tajiri, Kohei Nagata, et al.. (2016). Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir. Case Reports in Gastroenterology. 10(2). 352–359. 1 indexed citations
10.
Tajiri, Kazuto, Koichi Tsuneyama, Kengo Kawai, et al.. (2014). A case of progressing focal nodular hyperplasia and its molecular expression pattern. Clinical Journal of Gastroenterology. 7(3). 271–277. 4 indexed citations
11.
Motoo, Iori, Terumi Takahara, Kengo Kawai, et al.. (2013). Two cases of hepatic angiomyolipoma with difficulty for imaging differential diagnosis with hepatocellular carcinoma. Kanzo. 54(2). 143–151.
12.
Tajiri, Kazuto, et al.. (2013). A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab. Case Reports in Gastroenterology. 7(1). 195–201. 6 indexed citations
13.
Luo, Xiaoyu, Terumi Takahara, Kengo Kawai, et al.. (2011). Theaflavin attenuates ischemia–reperfusion injury in a mouse fatty liver model. Biochemical and Biophysical Research Communications. 417(1). 287–293. 37 indexed citations
14.
Minemura, Masami, Shinya Kajiura, Yoshiharu Tokimitsu, et al.. (2011). [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].. PubMed. 38(2). 309–12. 2 indexed citations
15.
Zhang, Wei, Hiroshi Kudo, Kengo Kawai, et al.. (2010). Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications. 391(4). 1731–1736. 47 indexed citations
16.
Takahara, Takeshi, et al.. (2009). Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. Journal of Hepatology. 51(1). 168–175. 136 indexed citations
17.
Kawai, Kengo, Yoshinari Atarashi, Terumi Takahara, et al.. (2009). Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clinical Journal of Gastroenterology. 2(2). 119–124. 2 indexed citations
18.
Kudo, Hiroshi, Yutaka Yata, Terumi Takahara, et al.. (2009). Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Liver International. 29(7). 988–996. 76 indexed citations
19.
Takahara, Terumi, Feng Xue, Massimiliano Mazzone, et al.. (2008). Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology. 47(6). 2010–2025. 13 indexed citations
20.
Takahara, Terumi, Yutaka Yata, Feng Xue, et al.. (2007). Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. American Journal of Physiology-Gastrointestinal and Liver Physiology. 293(1). G230–G239. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Levene Breakdown of academic impact, for papers by Mehdi Ramezani–Moghadam Breakdown of academic impact, for papers by Yosuke Aihara Breakdown of academic impact, for papers by Tomohiko Ohashi Breakdown of academic impact, for papers by Hyo‐Suk Lee Breakdown of academic impact, for papers by Jennifer Demieville Breakdown of academic impact, for papers by Ali Mencin Breakdown of academic impact, for papers by Nozomu Wada Breakdown of academic impact, for papers by Rie Irie Breakdown of academic impact, for papers by Sara Aleffi
Rankless by CCL
2026